• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Yehuda Handelsman Discusses New Alternatives to Basal Insulin

News
Video

Recent advances in insulin formulations and innovative drug classes have made it easier than ever to manage diabetic patients’ glucose levels, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.

Recent advances in insulin formulations and innovative drug classes have made it easier than ever to manage diabetic patients’ glucose levels, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.

Related Videos
Steven Manobianco, MD
Xiaotong Li, PhD, MS, Memorial Sloan Kettering Cancer Center
Dr Amrita Basu
Justin Drake, PhD
Joanna Rhodes, MD, MSCE, director of the lymphoma program at the Rutgers Cancer Institute and the assistant head of lymphoma at Robert Wood Johnson Medical School
Ira Zackon, MD, senior medical director, Ontada
Shayla Bergmann, MD, a clinical professor in pediatric hematology at the Medical University of South Carolina
Erika Hamilton, MD
Ivo Carre, PhD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.